Cargando…
Immune Response Mechanisms against AAV Vectors in Animal Models
Early preclinical studies in rodents and other species did not reveal that vector or transgene immunity would present a significant hurdle for sustained gene expression. While there was early evidence of mild immune responses to adeno-associated virus (AAV) in preclinical studies, it was generally b...
Autores principales: | Martino, Ashley T., Markusic, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965504/ https://www.ncbi.nlm.nih.gov/pubmed/31970198 http://dx.doi.org/10.1016/j.omtm.2019.12.008 |
Ejemplares similares
-
Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011) -
Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016) -
Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021) -
Single-dose AAV vector gene immunotherapy to treat food allergy
por: Gonzalez-Visiedo, Miguel, et al.
Publicado: (2022)